A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice
Open Access
- 1 September 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (9) , 1724-1733
- https://doi.org/10.1038/sj.mt.6300235
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- HIV VACCINESAnnual Review of Immunology, 2006
- DNA Vaccines: Progress and ChallengesThe Journal of Immunology, 2005
- A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansJournal of General Virology, 2004
- Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humansNature Medicine, 2003
- Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector BoostingJournal of Virology, 2003
- Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA VaccinationScience, 2000
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNAVaccine, 1993
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983